Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

What is the potential for using monoclonal antibodies in multiple myeloma?

Prof Sagar Lonial, Prof Pieter Sonneveld, Prof Jesús San Miguel
What is the potential for using monoclonal antibodies in multiple myeloma? ( Prof Sagar Lonial, Prof Pieter Sonneveld, Prof Jesús San Miguel )
6 Oct 2015

Expert discussion on current experience with monoclonal antibodies in multiple myeloma

Prof Antonio Palumbo and Prof Philippe Moreau
Expert discussion on current experience with monoclonal antibodies in multiple myeloma ( Prof Antonio Palumbo and Prof Philippe Moreau )
6 Oct 2015

ECC 2015: Editor's highlights

Prof Gordon McVie - ecancer Managing Editor
ECC 2015: Editor's highlights ( Prof Gordon McVie - ecancer Managing Editor )
5 Oct 2015

Roundtable discussion on CLL: Expert insights from the iwCLL congress

Dr Paula Cramer, Prof Robin Foà, Dr Steve Coutre, Dr Constantine Tam
Roundtable discussion on CLL: Expert insights from the iwCLL congress ( Dr Paula Cramer, Prof Robin Foà, Dr Steve Coutre, Dr Constantine Tam )
2 Oct 2015

First ‘targeted’ treatment for small cell lung cancer shows promise

Dr Catherine Pietanza - Memorial Sloan Cancer Center, New York, USA
First ‘targeted’ treatment for small cell lung cancer shows promise ( Dr Catherine Pietanza - Memorial Sloan Cancer Center, New York, USA )
2 Oct 2015

Mantle cell lymphoma current treatment practices

Prof Georg Hess, Prof Christian Buske, Prof Steven Le Gouill, Prof Eva Kimby
Mantle cell lymphoma current treatment practices ( Prof Georg Hess, Prof Christian Buske, Prof Steven Le Gouill, Prof Eva Kimby )
2 Oct 2015

Examining NSCLC responses to durvalumab monotherapy

Brandon Higgs - MedImmune, Gaithersburg, USA
Examining NSCLC responses to durvalumab monotherapy ( Brandon Higgs - MedImmune, Gaithersburg, USA )
1 Oct 2015

ECC 2015 scientific highlights

Prof Peter Naredi - University of Gothenburg, Gothenburg, Sweden
ECC 2015 scientific highlights ( Prof Peter Naredi - University of Gothenburg, Gothenburg, Sweden )
30 Sep 2015

Atezolizumab limits disease progression for metastatic urothelial bladder cancer

Dr Jonathan E. Rosenberg - Memorial Sloan Kettering Cancer Center, New York, USA
Atezolizumab limits disease progression for metastatic urothelial bladder cancer ( Dr Jonathan E. Rosenberg - Memorial Sloan Kettering Cancer Center, New York, USA )
30 Sep 2015

Atezolizumab for locally advanced or metastatic PD-L1-selected NSCLC

Dr Benjamin Besse - Institut Gustave Roussy, Villejuif, France
Atezolizumab for locally advanced or metastatic PD-L1-selected NSCLC ( Dr Benjamin Besse - Institut Gustave Roussy, Villejuif, France )
30 Sep 2015

Rova-T: First ‘targeted’ treatment for small cell lung cancer shows promise

Dr Catherine Pietanza - Memorial Sloan Kettering Cancer Center, New York, USA
Rova-T: First ‘targeted’ treatment for small cell lung cancer shows promise ( Dr Catherine Pietanza - Memorial Sloan Kettering Cancer Center, New York, USA )
28 Sep 2015

Multi-peptide vaccine for kidney cancer fails to improve survival

Dr Brian Rini - Cleveland Clinic Foundation, Cleveland, USA
Multi-peptide vaccine for kidney cancer fails to improve survival ( Dr Brian Rini - Cleveland Clinic Foundation, Cleveland, USA )
28 Sep 2015